Insider filing · ETON
Eton Pharmaceuticals, Inc.
ETON · Healthcare · 14 filings in 24 months
ticker →
Opaleye Management Inc. sold $4.8M of Eton Pharmaceuticals (ETON)
Executed Jul 2, disclosed Jul 7, 5 days later.
Value, as filed
$4.8M
126,685 sh across 5 lots
Executed
Jul 2
the trade date, as filed
Disclosed
Jul 7
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
OI
Opaleye Management Inc.
10% owner
profile →
Opaleye Management Inc. (10% owner) filed 41 Form 4 reports as a reporting entity in the trailing twelve months (27 purchases, 14 sales, 3 filed past the two-business-day deadline), most often in CDXS. Across 24 priced purchase filings, the average 21-session return was +14.8% from execution and +15.1% from disclosure (delay-adjusted; derived). The largest single filing was $7.8M of HROW (197,263 sh across 3 lots, as filed), executed Mar 3.
The name
ETONHealthcare · Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Opaleye Management Inc. in ETON
ETONSALE
Eton Pharmaceuticals, Inc.
$1.1M28,315 sh across 2 lots
Exec Jul 14
Filed Jul 17 · 7:12 PM ET † ETONSALE Eton Pharmaceuticals, Inc. $1.1M
28,315 sh across 2 lots
Exec Jul 14
Filed Jul 16 · 5:14 PM ET